[1] |
CHEN Yugang, TU Yanqiong, WANG Congqing, CHEN Juan, ZHANG Bohong.
Network pharmacology and molecular docking to discuss the mechanism of Jinhutongdan prescription in the treatment of cholelithiasis and experimental verification
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(10): 1090-1098.
|
[2] |
TIAN Dahao, LU Linming, ZHI Hui, ZHOU Jue, WANG Xiaoqing, JIANG Yuhua.
AHVAC-I inhibits the proliferation in human primary gastric cancer cells
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(5): 505-511.
|
[3] |
LI Hui, CHEN Jun, XU Caihong, PANG Linrong, CHENG Xiaochun.
Antitumor effect of salvianolic acid A and on its reversal of multidrug resisitance in A549/MTX tumor
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(11): 1244-1247.
|
[4] |
DENG Junli, ZHANG Rui, TANG Jie, WANG Guo, ZHU Yuanshan.
Research progress on the anti-tumor effects of statins
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(1): 92-99.
|
[5] |
CHEN Yan, YE Bin, MOU Wen-yuan, YU Cheng-bo, LIN Bu, YIN Xiang-peng, XU Hong-miao.
Effect of anti-tumor necrosis factor antibody on TRAIL and TNF-α expression induced by lipopolysaccharide in human periodontal ligament fibroblasts
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2015, 20(5): 493-498.
|
[6] |
YANG De-xuan, LI Lin-na, WANG Shan-shan, YUAN Shou-jun.
Evaluation of anti-tumor effect of epothilone B on human lung cancer A549 cell in vitro and in vivo
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(11): 1201-1205.
|
[7] |
YU Wen-ying, ZHANG Liang, CHEN Guo-shen, YE Jin-cui.
Research progress in application of multi-component mixtures of enhancers in transdermal drug delivery
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(1): 103-109.
|
[8] |
CHEN Shu-qing, ZHONG Zheng-ling, LI Hai-tao, LI Juan, CHU Ji-ru.
Research progress on chemical constituents and pharmacological effects of poplar bud extracts
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2012, 17(11): 1302-1306.
|
[9] |
SHANG Li-li, SUN Jian-guo, XIE Hai-tang, WANG Guang-ji.
Saponins in tumor therapy
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(2): 225-232.
|
[10] |
YUE Lei, CHEN Ling, KOU Jun-ping, YU Bo-yang.
Recent advances of diosgenin in its pharmacologic activities and mechanism
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(2): 233-237.
|
[11] |
YANG Jun, LUO Jing-jing, HU Xiu-fang.
Construction of recombinant adenovirus containing tumor -targeting fusion RGD-IL-24 gene and analysis of its activity in vitro
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(11): 1223-1228.
|
[12] |
YANG Jie-ren, WU Xiang-qi, ZHOU Yong, HUANG Kai, XIONG Ke-ren, CHEN Guo-xiang.
Synergistic protective effects of sesamin in combination with vitamin E on nephropathy in rats with metabolic syndrome
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(6): 629-636.
|
[13] |
MAO Jie, XU Shan-shui, SHEN Li-li, WANG Xuan-zhi.
Advances in the studies on the anti-tumor effect and mechanism of baicalein
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(10): 1178-1182.
|
[14] |
SONG Yu, SONG Ying, KANG Zhi-chen, ZHAO Wen-jie, LIU Xiao-xi, DENG Xu-ming.
Research on anti-tumor activity of evodiamine in vitro
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2008, 13(8): 860-864.
|
[15] |
HE Kang, FENG You-hui, AI Chun-mei.
Experimental study on anti-tumor effect of chitosan sulfate in mice
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2008, 13(1): 103-106.
|